Evidence for Membrane-Bound Antibodies Directed against Antigens Expressed on Tumors

  • S. von Kleist
  • M. King
  • C. Huet
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 10)


The possible existence in the cancer patient of an effective defense mechanism against his malignancy is of high clinical interest and has prompted numerous investigations yielding both positive and negative results (for reviews, see Baldwin et al.,1973; Sjögren, 1976; Prehn, 1976; Witz, 1977).


Carcinoembryonic Antigen Human Malignant Melanoma Colonic Tumor Cyanuric Chloride Tumor Cell Membrane 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Avrameas, S., Taudou, B., and Chuilon, S., 1969, Glutaraldehyde, cyanuric chloride and tetrazotized O-dianizide as coupling reagents in the passive hemagglutination test, Immunochemistry 6: 67–76.PubMedCrossRefGoogle Scholar
  2. Baldwin, R. W., and Price, M.R., 1976, Nature and expression of tumour antigens associated with experimental animal and human tumours, Ann. Clin. Biochem. 13: 488–94.PubMedGoogle Scholar
  3. Baldwin, R. W., Bowen, J. G., and Price, M. R., 1973, Detection of circulating hepatoma D23 antigen and immune complexes in tumor bearer serum, Br. J. Cancer 28: 16–24.PubMedCrossRefGoogle Scholar
  4. Baldwin, R. W., Embleton, M. J., Jones, J. S., et al.,1973, Cell-mediated and humoral immune reactions to human tumours, Int. J. Cancer 12:73–83.Google Scholar
  5. Bernstein, I., Hellström, K. E., and Wright, P. W., 1976, Immunity to tumor antigens: Potential implications in human neuroblastoma, J. Natl. Cancer Inst. 57: 711–715.PubMedGoogle Scholar
  6. Braslawsky, G., Ran, M., and Witz, I. P., 1976, Tumor-bound immunoglobulins: The relationship between the in vivo coating of tumor cells by potentially cytotoxic antitumor antibodies and the expression of immune complex receptors, Int. J. Cancer 18: 116–121.PubMedCrossRefGoogle Scholar
  7. Bull, D. M., Leibach, J. R., Williams, M. A., et al.,1973, Immunity to colon cancer assessed by antigen induced inhibition of mixed mononuclear cell migration, Science 181:957–959.Google Scholar
  8. Churchill, W. H., Jr., Rapp, H. J., Kronman, B. S., et al.,1968, Detection of antigens of a new diethyl-nitrosamine induced transplantable hepatoma by delayed hypersensitivity, J. Natl. Cancer Inst. 41:13–17.Google Scholar
  9. Cohen, A. ìvI., Ketcham, A. S., and Morton, D. L., 1973, Tumor specific cellular cytotoxicity to human sarcomas: Evidence for a cell mediated host immune response to a common sarcoma cell surface antigen, J. Natl. Cancer Inst. 50: 585–589.PubMedGoogle Scholar
  10. Collatz, E., von Kleist, S., and Burtin, P., 1971, Further investigations of circulating antibodies in colon cancer patients on the autoantigenicity of the carcino-embryonic antigen, Int. J. Cancer 8: 298–303.PubMedCrossRefGoogle Scholar
  11. Constanza, M. E., Pim, V., Schwartz, R. S., et al.,1973, Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome, N. Engl. J. Med. 289:520–522.Google Scholar
  12. Coons, A. H., Leduc, E. H., and Connolly, J. M., 1955, Studies on the antibody production, J. Exp. Med. 102: 49–59.PubMedCrossRefGoogle Scholar
  13. Dorsett, B. H., Ioachim, H. L., Stollbach, L., et al.,1975, Isolation of tumor-specific antibodies from effusions of ovarian carcinomas, Int. J. Cancer 16:779–786.Google Scholar
  14. Edynak, E. M., Old, L. J., Vrana, M., et al.,1970. A fetal antigen in human tumours: Detection by an antibody in the serum of cancer patients, Proc. Am. Assoc. Cancer Res. 11:22.Google Scholar
  15. Eilber, F. R., and Morton, D. L., 1970, Sarcoma-specific antigens: Detection by complement fixation with serum from sarcoma patients, J. Natl. Cancer Inst. 44: 651–656.PubMedGoogle Scholar
  16. Fossati, G., Colnaghi, M. J., Porta, G. D., et al.,1971, Cellular and hum oral immunity against human malignant melanoma, Int. J. Cancer 8:344–350.Google Scholar
  17. Gold, Ph., 1967, Circulating antibodies against carcinoembryonic antigens of the human digestive system, Cancer 20: 1663–1664.CrossRefGoogle Scholar
  18. Gold, Ph., and Freedman, S. O., 1965, Specific carcinoembryonic antigens of the human digestive system, J. Exp. Med. 122: 467–481.PubMedCrossRefGoogle Scholar
  19. Gold, J. M., Freedman, S. O., and Gold, Ph., 1972, Human anti- CEA antibodies detected by radioimmunoelectrophoresis, Nature (London) New Biol. 239: 60–62.Google Scholar
  20. Graham, J. B., and Graham, R. M., 1955, Antibodies elicited by cancer in patients, Cancer 8: 406–419.Google Scholar
  21. Gupta, K. R., and Morton, D. L., 1975, Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas, Cancer Res. 35: 58–62.PubMedGoogle Scholar
  22. Haskill, J. S., and Fett, J. W., 1976, Possible evidence for antibody dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo, J. Immunol. 117: 1992–1998.PubMedGoogle Scholar
  23. Haskill, J. S., Radov, L. A., Yamamura, Y., et al.,1976, Isolation and indentification of specific and non-specific effector cells in experimental solid tumors, J. Reticuloendothel. Soc. 20:233–243.Google Scholar
  24. Hellström, K. E., and Hellström, J., 1974, Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens, Adv. Immunol. 18: 209–277.PubMedCrossRefGoogle Scholar
  25. Hellström, J., Hellström, K., and Shepard, T., 1970, Cell mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium, Int. J. Cancer 6: 346351.Google Scholar
  26. Hellström, J., Hellström, K. E., Sjögren, H. O., et al., 1971a,Demonstration of cell-mediated immunity to human neoplasms of various histological types, Int. J. Cancer 7:1–16.Google Scholar
  27. Hellström, J., Sjögren, H. O., Warner, G., et al.,1971 b,Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasmas, Inn. J. Cancer 7:226–237.Google Scholar
  28. Herberman, R. B., 1974, Delayed hypersensitivity skin reactions to antigens on human tumors, Cancer 34 (Suppl.): 1469–1473.PubMedCrossRefGoogle Scholar
  29. Herberman, R. B., and Oren, M. E., 1969, Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumor cells, Clin. Res. 17: 403–405.Google Scholar
  30. Hodkinson, M., and Taylor, G., 1969, Autoimmune responses to human tumour antigens, Br. J. Cancer 23: 510–514.PubMedCrossRefGoogle Scholar
  31. Hollinshead, A. C., Macwright, C. G., and Glew, D. H., 1972, Separation of skin reactive intestinal cancer antigen from the carcinoembryonic antigen of Gold, Science 177: 887–889.PubMedCrossRefGoogle Scholar
  32. Itoh, T., and Southam, C. M., 1964, Isoantibodies to human cancer cells in cancer patients following cancer homotransplants, J. Immunol. 93: 916–936.Google Scholar
  33. Johannson, B., and Ljunqvist, A., 1974, Localization of immunoglobulin in urinary bladder tumors, Acta Pathol. Microbiol. Scand. Sect. A 82: 559–563.Google Scholar
  34. Jose, D. G., and Seshadri, R., 1974, Circulating immune complexes in human neuroblastoma: Direct assay and role in blocking specific cellular immunity, Int. J. Cancer 13: 824–838.PubMedCrossRefGoogle Scholar
  35. Kahan, B. D., 1967, Cutaneoushypersensitivity reactions of guinea pigs to proteinaceous transplantation antigen, J. Immunol. 99: 1121–1127.PubMedGoogle Scholar
  36. Lamon, E. W., Whitten, H. D., Skurzak, H. M., et al.,1975, IgM antibody dependent cell mediated cytotoxicity in the moloney sarcoma virus system: The involvement of T and B lymphocytes as effector cells, J. Immunol. 115:1288–1297.Google Scholar
  37. Lewis, M. G., and Phillips, T. M., 1972, The specificity of surface membrane immunofluorescence in human malignant melanoma, Int. J. Cancer 10: 105–111.PubMedCrossRefGoogle Scholar
  38. Lewis, M. G., Loughridge, L. W., and Phillips, T. M., 1971, Immunologic studies in nephritic syndrome associated with extravenal malignant disease, Lancet 2: 134–135.PubMedCrossRefGoogle Scholar
  39. Lewis, M. G., Proctor, J. W., Thomson, D. M. P., et al.,1976, Cellular localization of immunoglobulin within human malignant melanoma, Br. J. Cancer 33:260–266.Google Scholar
  40. Lo Gerfo, P., Herter, F. P., and Bennett, S. J., 1972, Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies, Int. J. Cancer 9: 344–348.PubMedCrossRefGoogle Scholar
  41. Mach, J. P. and Pusztaszeri, G., 1972, CEA: Demonstration of a partial identity between CEA and a normal glycoprotein, Immunochemistry 9: 1031–1034.PubMedCrossRefGoogle Scholar
  42. Mavligit, G. M., Ambus, U., Gutterman, J. U., et al.,1973, Antigen solubilized from human solid tumours-Lymphocyte stimulation and cutaneous delayed-hypersensitivity, Nature (London) New Biol. 243:188–190.Google Scholar
  43. Muna, N. M., Marcus, S., and Smart, C., 1969, Detection of immunofluorescence of antibodies specific for human malignant melanoma cells, Cancer 23: 88–95.PubMedCrossRefGoogle Scholar
  44. Oren, M. E., and Herberman, R. B., 1971, Delayed cutaneus hypersensitivity reactions to membrane extracts of human tumour cells, Clin. Exp. Immunol. 9:45–56.Google Scholar
  45. Prehn, R. T., 1976, Do tumors grow because of the immune response of the host? Transplant. Rev. 28: 34–42.PubMedGoogle Scholar
  46. Ran, M., Fish, F., Witz, I. P., et al.,1974, Tumor-bound immunoglobulins: The in vitro disappearance of immunoglobulin from the surface of coated tumor cells, and some properties of released components, Clin. Exp. Immunol. 16:335–359.Google Scholar
  47. Ran, M., Klein, G., and Witz, I. P., 1976, Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies, Int. J. Cancer 17: 90–97.PubMedCrossRefGoogle Scholar
  48. Saksela, E., Imir, T., and Mäkelä, 0., 1975, Specifically cytotoxic human and mouse lymphoid cells induced with antibody antigen or antibody complexes, J. Immunol. 115: 1488–1492.PubMedGoogle Scholar
  49. Samayoa, E. A., McDuffie, F. C., Nelson, A. M., et al.,1977, Immunoglobulin complexes in sera of patients with malignancy, Int. J. Cancer 19:12–17.Google Scholar
  50. Schultz, R. M., Woods, W. A., and Chingos, M. A., 1975, Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum, Int. J. Cancer 16: 16–23.PubMedCrossRefGoogle Scholar
  51. Sjögren, H. 0., 1976, Immunological aspects of colorectal cancer Clin. Gastroenterol 5: 563–571.Google Scholar
  52. Sjögren, H. 0., Hellström I., Bansal, S. C., et al.,1971, Suggestive evidence that the “blocking antibodies” of tumor bearing individuals may be antigen-antibody complexes, Proc. Natl. Acad. Sci. USA 68:1372–1375.Google Scholar
  53. Sjögren, H. O., Hellström, I., Bansal, S. C., et al.,197/, Elution of “blocking factors” from human tumors capable of abrogating tumor cell destruction by specifically immune lymphocytes, Int. J. Cancer 9:274–283.Google Scholar
  54. Sorokin, J. J., Kupchick, H. Z., and Zamcheck, N., 1973, Carcinoembryonic antigen in colon cancer: Absence in perchloric acid precipitates of plasma, J. Natl. Cancer Inst. 51: 1081–1083.PubMedGoogle Scholar
  55. Sulitzeanu, D., Gorsky, Y., and Morecky, S., 1976, Membrane bound immunoglobulin on cells of effusions from patients with malignant diseases, Isr. J. Med. Sci. 12: 1329 1331.Google Scholar
  56. Thomson, D. M. B., and Alexander, P., 1973, A cross-reacting embryonic antigen in the membrane of rat sarcoma cells which is immunogenic in the syngeneic host, Br. J. Cancer 27: 35–47.PubMedCrossRefGoogle Scholar
  57. Thunold, S., Tönder, O., and Larsen, 0., 1973, Immunoglobulins in eluate of malignant human tumors, Acta Pathol. Microbiol. Scand. Suppl. 236: 97–100.PubMedGoogle Scholar
  58. von Kleist, S., and Burtin, P., 1977, The carcinoembryonic antigen (CEA) and other carcinofetal antigens in gastrointestinal cancers and benign diseases, Prog. Gastroenterol. III: 595–615.Google Scholar
  59. von Kleist, S., and Burtin, P., 1979, Antigens crossreacting with CEA, in: Immunodiagnosis of Cancer ( R. B. Herbermann and K. R. McIntire, eds.), pp. 322–342, Marcel Dekker, Inc., New York.Google Scholar
  60. von Kleist, S., Chavanel, G., and Burtin, P., 1972, Identification of a normal antigen that cross reacts with the carcinoembryonic antigen. Proc. Natl. Acad. Sci. USA 69: 249294.Google Scholar
  61. von Kleist, S., King, M., and Burtin, P., 1974, Charactization of a normal tissular antigen extracted from human colonic tumors, Immunochemistry 11: 249–253.PubMedCrossRefGoogle Scholar
  62. von Kleist, S., Chany, E., Burtin, P., et al.,1975, Immunohistological study of the antigenic pattern of a continuous human colonic tumor cell line (HT 29), J. Natl. Cancer Inst. 55:555–560.Google Scholar
  63. von Kleist, S., Tronpel, S., King, M., et al.,1977, A clinical comparison between non-specific crossreacting antigen (NCA) and CEA in patients’ sera, Br_.1. Cancer 35:875–880.Google Scholar
  64. von Kleist, S., King, M., and Haveysmann, K., 1978, Demonstration of antibodies in patients’ sera directed against non specific cross-reacting antigen, J. Natl. Cancer Inst. 61: 1385 1391.Google Scholar
  65. Witz, I. P., 1973, The biological significance of tumor-bound immunoglobulins, Curr. Top. Microbiol. Immunol. 61: 151–171.PubMedGoogle Scholar
  66. Witz, I. P., 1977, Tumor-bound immunoglobulins: In situ expressions of humoral immunity, Adv. Cancer Res. 25: 95–148.PubMedCrossRefGoogle Scholar
  67. Witz, I. P., Kinnamon, S., and Ran, M., et al.,1974, Tumor-bound immunoglobulins: The in vitro fixation of radioiodine labeled anti-immunoglobulin reagents by tumor cells, Clin. Exp. Immunol. 16:321–334.Google Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • S. von Kleist
    • 1
  • M. King
    • 2
  • C. Huet
    • 2
  1. 1.Institute of Tumor ImmunologyUniversity of FreiburgFreiburg im BreisgauGermany
  2. 2.Institut de Recherches Scientifiques sur le CancerVillejuifFrance

Personalised recommendations